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Abstract
In the last twenty years new antibacterial agents approved by the U.S. FDA decreased whereas in parallel the resistance
situation of multi-resistant bacteria increased. Thus, community and nosocomial acquired infections of resistant bacteria led
to a decrease in the efficacy of standard therapy, prolonging treatment time and increasing healthcare costs. Therefore, the
aim of this work was to demonstrate the applicability of cold atmospheric plasma for decolonisation of Gram-positive
(Methicillin-resistant Staphylococcus aureus (MRSA), Methicillin-sensitive Staphylococcus aureus) and Gram-negative bacteria
(E. coli) using an ex vivo pig skin model. Freshly excised skin samples were taken from six month old female pigs (breed:
Pietrain). After application of pure bacteria on the surface of the explants these were treated with cold atmospheric plasma
for up to 15 min. Two different plasma devices were evaluated. A decolonisation efficacy of 3 log10 steps was achieved
already after 6 min of plasma treatment. Longer plasma treatment times achieved a killing rate of 5 log10 steps
independently from the applied bacteria strains. Histological evaluations of untreated and treated skin areas upon cold
atmospheric plasma treatment within 24 h showed no morphological changes as well as no significant degree of necrosis or
apoptosis determined by the TUNEL-assay indicating that the porcine skin is still vital. This study demonstrates for the first
time that cold atmospheric plasma is able to very efficiently kill bacteria applied to an intact skin surface using an ex vivo
porcine skin model. The results emphasize the potential of cold atmospheric plasma as a new possible treatment option for
decolonisation of human skin from bacteria in patients in the future without harming the surrounding tissue.
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Introduction
Eradication of multiresistant superbugs is one of the clinical
challenges of the 21st century [1]. In addition the situation will
further exacerbate, because the pipeline of new antibiotics is not
fully straight. The Infectious Diseases Society of America (IDSA)
highlights that, over the past several years, the number of new
antibacterial drugs approved continues to decrease [2,3]. Only
three of the eight antibiotics approved within the last decade act
towards a new mechanism of action, whereas all the others are
only modifications of already known antibiotics. In parallel, the
resistance of S. aureus increased substantially: Nowadays a total of
,21% of Staphylococcus aureus in Germany are resistant to
methicillin/oxacillin [4]. Klevens reported that the overall
increase of methicillin-resistant S. aureus (MRSA) resistance was
3.1% per year in USA, based on a linear model from 1992–2003
[5]. Thus, there is great interest in new antimicrobial strategies to
overcome the lack of new anti-invectives. Recently cold atmo-
spheric plasma has demonstrated both bactericidal, virucidal and
fungicidal properties due to the generation of reactive species and
charged particles [6,7,8]. Numerous studies demonstrated the
effectiveness of gas-discharge or cold atmospheric plasmas for
killing especially planktonic microorganisms [7,9,10,11]. Further-
more a successful disinfection of methicillin-resistant Staphylococcus
aureus and Staphylococcus epidermidis biofilms was demonstrated using
a remote non-thermal gas plasma [12].
In the context of decreasing numbers of new antibacterial drugs
and increasing resistance of bacteria the effective disinfection of
hospital surfaces is of major interest as an important factor in
preventing hospital-acquired infections. First attempts were shown
by Burts et al. who was able to demonstrate that disinfection of
hospital pagers experimentally coated with MRSA could be
achieved within 30 seconds of plasma treatment [13]. In general
cold atmospheric plasma, which means less than 40uC at the point
of application, can be produced in air in order to produce reactive
molecules like atoms, ions and radicals. This chemical ‘‘cocktail’’
of reactive species can be used for different biomedical
applications. The killing efficacies of plasma were in the same
range as standard antimicrobial agents, up to 3–5 log10 steps [13].
However, to our knowledge, there are only few reports about the
use of cold atmospheric plasma for decolonization of bacteria
applied to vital skin surfaces [14,15]. Lademann et al. for example
used a plasma tissue tolerable plasma jet and achieved a reduction
of the bacteria load of 94% using an ex vivo ear pig skin model [15].
However this plasma jet is able to disinfect only small skin areas
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10 mm/sec on the skin surface.
For demonstrating the killing efficacies of new disinfecting
agents an ex vivo porcine skin model was developed in our lab [16].
This model was used, as it serves as an alternative skin model for
human skin based on many similarities regarding behaviour,
composition, histological, physiological and permeability proper-
ties [17,18]. The challenge of the antimicrobial plasma treatment
is to find appropriate parameters which inactivate bacteria without
harming the surrounding tissue. Therefore the present study was
performed to evaluate the efficacy of two different cold-
atmospheric plasma devices for decolonisation of $3 log10 steps
($99.9%) of S. aureus, MRSA and E. coli on large skin areas when
these bacteria were applied to an ex vivo porcine skin model.
Materials and Methods
Bacterial strains
The bacterial strains Escherichia coli (atcc 25922), methicillin-
sensitive Staphylococcus aureus (atcc 25923) and two methicillin-
resistant Staphylococcus aureus (MRSA: atcc BAA-44; attcc 43300)
were grown aerobically at 37uC in Mueller-Hinton broth (Carl
Roth GmbH+Co. KG, Karlsruhe, Germany). A 500 ml portion of
an overnight bacteria culture (3 ml) was transferred to 50 ml of
fresh BHI media and grown at 37uC on an orbital shaker. When
the cultures reached the stationary phase of growth, the bacteria
were harvested by centrifugation (200 g, 15 min), washed with
10 mM phosphate-buffered saline (PBS; Biochrom, Berlin,
Germany) at pH 7.4 containing 2.7 mM KCl and 0.14 M NaCl
and suspended in PBS at an optical density of 0.6 at 600 nm
corresponding to 10
6–7 bacteria ml
21.
Preparation of pig skin
Fresh skin from six month old female pigs (breed: Pietrain) was
obtained from a local slaughterhouse (Metzgerei Stierstorfer,
Wenzenbach, Germany). The preparation was done as already
published [16]. Briefly, the excised skin was washed with water,
epilated with a dry razor and the adipose tissue beneath the dermis
was removed with a scalpel. Then the skin was cut under sterile
conditions into 262c m
2 pieces, placed in a Petri dish and
embedded with Hepes Agar. The surface of the embedded skin
was then incubated with 70% ethanol for 5 min to reduce the
number of resident bacteria. After three washing steps with sterile
PBS, a known number of bacteria (10
6–7 ml
21 CFU) were applied
to the skin and the treatment with cold atmospheric plasma was
performed.
Plasma devices
Two different cold atmospheric plasma devices were evaluated.
FlatPlaSter. The FlatPlaSter plasma device is a box made
out of plastic (Teflon and polyoxymethylene) incorporating an
electrode for the plasma production inside as shown in figure 1A.
On one side of the box, a door is installed. By closing the door the
produced plasma gas cannot escape and therefore is confined
inside. This plasma device is designed for the treatment of a 96-
well plate (sample), so that the maximum treated area equals
9613 cm
2. The plasma electrode is placed above the sample and
the distance between the electrode and the sample is adjustable. In
our experiments, the distance to the pig skin surfaces was set to
6 mm. By using the ambient air a plasma discharge is ignited with
the SMD (Surface Micro-Discharge) plasma technique [19]. The
plasma electrode consists of a 0.5 mm thick Teflon plate
sandwiched by a brass planar plate and a stainless steel mesh
grid (line width 2 mm, opening 10 mm, height 1.5 mm). High
sinusoidal voltage of 9 kVpp with 1 kHz in frequency was applied
between the brass electrode and the mesh electrode thereby
producing the plasma discharges on the mesh side of the SMD
electrode as shown in figure 1B. The power consumption for the
plasma discharge was approximately 0.02 W/cm
2 measured with
the Lissajous method using a 0.1 mF capacitance.
miniFlatPlaSter. The plasma device (miniFlatPlaSter), the
sketch is shown in Fig. 2, is equipped with a surface micro-
discharge (SMD) electrode. This device was designed for portable
usage and the high voltage power supply and the accumulators are
incorporated. The SMD electrode consists of a copper foil layer
(around 0.2 mm thick), a glass Epoxy board (1 mm thick), and a
stainless steel mesh. The plasma is ignited on the mesh side of the
electrode by applying a high voltage signal between the copper foil
and the mesh. The voltage signal is pulse-like with a peak-to-peak
voltage of approximately 7 kV and a repetition frequency of
approximately 6.75 kHz. The size of the electrode is 28 mm in
diameter and the power consumption is approximately 0.5 W/
cm
2.
Plasma treatment
100 ml of bacteria (,10
6–7/ml) was applied to the epidermis of
each skin sample. Then the bacteria suspension was spread over
the complete skin area of interest using a sterile inoculation loop.
The samples were placed under a laminar flow cabinet for 60 min
until they were visibly dry. Different plasma treatment times were
investigated to determine the antimicrobial decolonization effect.
Quantification of plasma inactivation efficacy
Post plasma treatment a colony forming unit assay (CFU) was
performed to determine the surviving bacteria. A sterile cotton-
tipped rod was used to remove bacteria from the epidermis. For
each skin sample a cotton-tipped rod was moistened in sampling
buffer (0.1% Tween80, 0.0075 M phosphate puffer, pH 7.9)
before swabbing the entire surface three times. First the recovery
efficacy was tested to establish the range of viable numbers of CFU
per ml of untreated skin samples, which was in accordance with
already published data [16]. A reproducible correlation between
three swabbing steps and the recovery efficiency of bacteria
applied to the skin could be evaluated (data not shown). Survived
bacteria were detected with the Miles and Misra technique for
viable counts [20]. Serially diluted aliquots (20 ml) of treated and
untreated samples were plated on Mueller-Hinton agar, and the
number of CFU per millilitre was counted after 24 h of incubation
at 37uC.
Histology and histochemistry
Viability of each porcine skin sample was tested by detection of
dead cells using the in situ Cell Death Detection Kit according to
the manufacturer’s protocol (Roche, Penzberg, Germany). A
detailed description of the methodology is published elsewhere
[16]. Briefly, biopsies of porcine skin samples were embedded in
paraffin and sections of 3 mm thickness were cut and mounted on
microscope slides (SuperFrost Plus, Menzel Glasbearbeitungswerk
GmbH & Co. KG, Braunschweig, Germany). Sections were
permeabilised and treated with 3% of hydrogen peroxide to block
endogenous peroxidase. Thereafter a TUNEL-reaction was done
according to the manufacturer’s protocol. Labelling of DNA
strand breaks was done by addition of terminal deoxynucleotidyl
transferase, which catalyzes polymerization of fluorescein-labelled
nucleotides to free 39OH DNA ends in a template-independent
manner. Incorporated fluorescein was detected using a fluores-
cence microscope (Zeiss Axiotech, Goettingen, Germnay) with an
appropriate dual-band filter set (Omega opticals, Brattleboro, VT,
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(lem=535635 nm). After substrate reaction, the slides were co-
stained with DAPI (lex=365650 nm; lem=450658 nm) to
visualize all nuclei. Fluorescence images were superimposed with
an image processing program (Image-Pro Plus 5.0; Media
Cybernetics, Silver Spring, MD, USA). Negative (no addition of
terminal deoxynucleotidyl transferase or the labelled nucleotide
mixture of the TUNEL-reaction) and positive controls (addition of
Figure 1. Schematic image of the FlatPlaSter plasma device. a) The FlatPlaSter contains one SMD electrode and the samples (to treat) are
placed inside the device below the electrode. In this study the distance between the electrode and the sample surface was fixed at 6 mm. b) left: The
plasma discharge is shown. On the mesh-side of the electrode, the SMD plasma was produced. c) right: The spectrum of the SMD plasma observed in
front of the electrode with a distance of 6 mm is shown. The UV components in the range between 280–400 nm are mainly produced from nitrogen
molecules excited by electrons.
doi:10.1371/journal.pone.0034610.g001
Figure 2. Schematic image of the miniFlatPlaSter plasma device. The portable plasma device is equipped with a high voltage power supply,
accumulators, and a surface micro-discharge (SMD) electrode. The SMD electrode consists of a copper foil layer (around 0.2 mm thick), an Epoxy
board (1 mm thick), and a stainless steel mesh of 28 mm in diameter. The plasma device was fixed above the ex vivo skin embedded in Hepes-Agar.
doi:10.1371/journal.pone.0034610.g002
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experimental set up. The presence of dead cells within the
epidermis was defined as green stained nuclei with granular or
sometimes fragmented cell nuclei, whereas blue stained cells are
negative (DAPI). The number of stained (dead) cells per 100 cells
was scored on three individual slides. The number of apoptotic
cells was calculated as a percentage of the total number of counted
cells as described previously by Schacht et al. [21].
Statistical methods
All results are shown as medians, including the 25% and 75%
quartiles, which were calculated from the values of at least 3
independent experiments, each experiment was conducted in
triplicates, with Prism 4 for Windows (GraphPad Software Inc.,
San Diego, CA, U.S.A). The calculation (reduction of CFU/ml)
was referred to the untreated controls (non plasma treated). In
Figs. 3 and 4, medians on or below the dotted horizontal line in
red or green represent $99.9% efficacy or $99.999% of bacteria
cell killing corresponding to at least more than three magnitudes or
five magnitudes of log10 reduction compared to matching
untreated controls (non plasma treated). A reduction of at least
three magnitudes of log10 of viable median numbers of bacteria
cells was stated as biologically relevant with regard to the
guidelines of hand hygiene [22].
Calculation of D-value
The death-value (D-value) for each microorganism was defined
as the time which is required for one log10 or 90% reduction of the
initial bacteria number for the specific plasma treatment condition
[23].
Results
Plasma characteristics
The cold atmospheric plasmas produced in this study deliver
various agents to the samples: reactive oxygen and nitrogen species
(NO, NO2,O 3, OH, O*, etc.), charged particles (electrons, ions),
photons (UV, visible), and heat.
In our experiments, the thermal effect can be ruled out because
the increase in the gas temperature was at maximum 4 degrees for
10 minutes of plasma operation.
Due to the distance between the electrode and the sample in our
experimental setup (approximately 6 mm), the impact of charged
particles (low density around the samples) is very small.
The emitted UV light can be mainly observed from the N2
positive system between 280 and 420 nm in wavelength (see
spectrum in fig. 1C). In addition peaks in the UVC region
resulting from the NO c system can be detected. The UV power
density equals 25 nW/cm
2. Furthermore it was confirmed that the
UV photons (emitted by the plasma) alone did not have any
bactericidal effect for a treatment time of up to 120 s. These
experiments were carried out by placing a quartz glass plate
between the electrode and the respective bacteria samples, so that
only the UV light produced by the plasma could pass (data not
shown).
Taking all this into account, the main agents which contribute
to the inactivation of bacteria in this study are reactive species. As
already mentioned, many reactive species are produced by the
plasma and all of them can react with the samples. For example,
the ozone concentration in the FlatPlaSter (see figure 1A) was at
maximum 500 ppm and the concentration of NO2 was around a
few ppm.
Regarding the two used plasma devices, FlatPlaSter and
miniFlatPlaSter, there are no differences in property - both are
based on the same SMD technology. Of course, the densities of
reactive species, etc. were different because the discharge area,
discharge volume, and power input were different.
Time-dependent cold-atmospheric plasma toxicity
against S. aureus, MRSA and E. coli
First the antimicrobial effect of cold atmospheric plasma was
tested against different antibiotic sensitive and resistant bacteria
strains using the FlaPlaSter device (fig. 3 & 4). The data indicate
that S. aureus, MRSA or E. coli were killed depending on the
plasma treatment time. There was a considerable reduction of
CFU ml
21 of 3 log10 steps for S. aureus (D-value=3.7 min) and E.
coli (D-value=3.71 min) after only a plasma treatment time of
6 min using the FlatPlaSter device (fig. 3A/B). By increasing the
plasma treatment time up to 15 min the killing efficacy was
enhanced. Already a treatment time of 8 min achieved a killing
efficacy of $5 log10 (99.999% of the initial applied bacteria were
killed) for both bacteria strains. In order to investigate whether the
observed reduction of methicillin-sensitive S. aureus was indepen-
dent of the antibiotic resistance pattern, two different MRSA
strains were treated with the FlatPlaSter under conditions identical
to those for S. aureus and E. coli. Similar results were recorded when
the MRSA strain BAA-44 was treated with different plasma
treatment times (fig. 4). Already a plasma treatment time of 4 min
resulted in a killing efficacy of MRSA (BAA-44) of 3 log10 steps
(99.9%). Increasing the plasma treatment time to 8 min a killing
efficacy of 5 log10 steps (99.999%) was achieved (D-value=3.9 -
min). As expected, the plasma treatment of the second MRSA
strain (atcc 43300) resulted in a substantial decrease of CFU ml
21
as well (D-value=3.6 min). The mean reductions in CFU ml
21
were 3 log10 or 5 log10 upon plasma treatment of 4 or 8 min
respectively (data not shown).
The second set of experiments was devoted to studying the
efficiency of decolonisation of bacteria applied to ex vivo skin using
the miniFlatPlaSter as a handheld device (fig. 2). Figure 5 shows
the decrease of CFU ml
21 of S. aureus obtained with different
plasma treatment times. A decrease of ,3 log10 steps (,99.9%) of
viable S. aureus was achieved within 60 sec. Prolonging the plasma
treatment to 5 min resulted in a killing efficacy of $3 log10 steps
($99.9%) (fig. 5).
Viability of porcine skin after plasma treatment
In order to assess the influence of the plasma treatment time on
the viability of the ex vivo porcine skin under experimental
conditions a TUNEL assay was performed to analyse the number
of DNA damaged cells within the epidermis within 48 h after
treatment. Normal untreated skin samples embedded in Hepes
Agar did not show any morphological changes up to 48 h after the
treatment (data not shown). During the entire observation period a
total of 1266% of TUNEL-positive cells was counted within the
epidermis of untreated samples. Plasma treatment regardless of the
used plasma device and treatment time also showed no increase of
TUNEL-positive cells within 24 h (fig. 6). Only a small fraction of
positive stained, DNA damaged cells were detected within the
upper layers of the epidermis after 48 h, but this was indepen-
dently when the samples were treated or untreated (fig. 6E and
6F). No TUNEL-positve cells were detected within the dermis.
Discussion
In this study an ex vivo porcine skin model was used to evaluate
the antimicrobial decolonisation efficacy of cold-atmospheric
plasma against antibiotic-sensitive and resistant bacteria. The
results demonstrate that killing of MRSA, S. aureus and E. coli by
Decolonisation of Bacteria by Plasma
PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e34610Figure 3. Decolonisation of S. aureus and E. coli using the FlatPlaSter plasma device. Cold atmospheric plasma treatment of (A) S. aureus
(10
6–7/ml) (D-value=3.7 min) and (B) E. coli (10
6–7/ml) (D-value=3.71 min) applied to ex vivo skin using the FlatPlaSter device. Different plasma
treatment times were tested [sec]. A CFU assay was performed immediately after the plasma treatment. Black dotted line: baseline of viable bacteria
per ml; red dotted line: reduction of three log10 steps of viable bacteria (99.9%); green dotted line: reduction of five log10 steps of viable bacteria
(99.999%). (n=6, median 6 interquartile range).
doi:10.1371/journal.pone.0034610.g003
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underlying tissue. Freshly excised porcine skin was used, because it
is proposed as a good test model for human skin based on many
physiological and anatomical similarities [18]. Histological evalu-
ation of plasma-treated skin samples showed only a slight increase
of TUNEL-positive cells within the epidermis, indicating that the
porcine skin might be still vital. However 48 hours after the
plasma treatment we could detect TUNEL-positive cells in both
plasma-treated samples and the untreated controls. This means
that the observed damage to the eukaryotic cells is not directly
related to the plasma treatment rather than to the total cultivation
time of the ex vivo porcine skin. Furthermore cold atmospheric
plasma seems not to influence the underlying tissue, because no
TUNEL-positive cells were detected at or below the basal
membrane or the dermis. Bush and colleagues demonstrated in
their studies the feasibility of pig skin as a model substrate for
evaluating skin disinfectants [24]. However, in their study skin
samples were frozen prior to evaluation of topically applied new
Figure 4. Decolonisation of MRSA using the FlatPlaSter plasma device. Cold atmospheric plasma treatment of MRSA (BAA-44) (10
6–7/ml)
applied to ex vivo skin using the FlatPlaSter device. Different plasma treatment times were tested [min]. A CFU assay was performed immediately after
the plasma treatment. Black dotted line: baseline of viable bacteria per ml; red dotted line: reduction of three log10 steps of viable bacteria (99.9%);
green dotted line: reduction of five log10 steps of viable bacteria (99.999%). (n=6, median 6 interquartile range).
doi:10.1371/journal.pone.0034610.g004
Figure 5. Decolonisation of S. aureus using the miniFlatPlaSter plasma device. Cold atmospheric plasma treatment of S. aureus (10
7/ml)
applied to ex vivo skin using the miniFlatPlaSter device. Different plasma treatment times were tested [sec]. A CFU assay was performed immediately
after the plasma treatment. Black dotted line: baseline of viable bacteria per ml; red dotted line: reduction of one log10 step of viable bacteria (90%);
green dotted line: reduction of three log10 steps of viable bacteria (99.9%). (n=3, mean value 6 standard deviation).
doi:10.1371/journal.pone.0034610.g005
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samples. In spite of this, the results obtained by Bush et al. are
more related to the hand-washing technique than to test the
efficacy of new antimicrobial techniques using vital skin samples
[24]. Recently Messager et al. could demonstrate, when testing
several liquid disinfectants that antiseptics were more active in
combination with mechanical effects ex vivo [25]. The addition of a
mechanical effect by drill rubbing of two skin samples against each
other produced a significantly greater reduction of the bacterial
load [25]. In this study we demonstrated for the first time, that
cold atmospheric plasma achieved a killing efficacy of up to
99.999% against topically applied bacteria, inclusively MRSA, via
a contactless procedure without damaging the surrounding tissue
(Figs. 3, 4 and 5). Then non-linear bacterial reduction with regard
to the plasma treatment time may have several reasons:
With the used bacterial concentration of 10
6–7 per ml and
0.1 ml applied to an area of at maximum 4 cm
2 we get a bacterial
load of 2.5610
4–5 per cm
2 which is in the range of what is found
on human skin. For a typical bacterial cross sectional area of
2610
28 cm
2 this gives a probability of overlap of 5610
24 to
5610
23. This theoretical probability of overlap – assuming a
homogeneous distribution - is negligible and so is biofilm
formation. However, there could still be concentrations of bacteria
in skin folds or follicles. This is something difficult to rule out. Our
primary aim in this study was to investigate whether the plasma
technique could be useful for the inactivation of an antibiotic-
resistant planktonic bacteria strain on skin but some concentration
fluctuations cannot be ruled out on ‘‘real’’ surfaces like skin. As we
pointed out this may happen even when the bacteria density is
low. This could then be one of the reasons why the bacterial
reduction rate is not linear.
Furthermore the non-linear reduction can also be explained by
the necessity of a certain treshold value: enough reactive species
have to be generated by the respective plasma device -above this
value bacteria can then be killed very efficiently.
Therefore we can only define an overall treatment time where
we achieve a 3 or 5-log10 reduction of CFU/ml as described in the
Results section.
Figure 6. Histological evaluation of ex vivo porcine skin after plasma treatment. TUNEL staining of skin sections after the plasma treatment
of skin samples inoculated with bacteria. (A) Positive control: incubation with 300 U DNase; (B) negative control; (C) immediately after the 15 min
plasma treatment; (D) 24 h after the 15 min plasma treatment; (E) 48 h after the 15 min plasma treatment; (F) 48 h of an untreated skin sample
(406magnifications).
doi:10.1371/journal.pone.0034610.g006
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resistant bacteria is of interest for controlling and preventing
bacterial spread in hospital daily routine. Recently Krishna and
colleagues reviewed the available literature on the use of
disinfectants for MRSA decolonisation. They concluded that the
clinical outcome of an octenidine/dihydrochlorine solution for
eradication of MRSA varied strongly between 6% and 75% [26].
In a further study of Johnson et al. which examined the successful
decolonisation of MRSA by means of an alcohol/chlorhexidine
hygiene solution, the consumption of the disinfection solution
increased from 5.7 to 28.6 L/1000 bed-days [27]. In another
study successful decolonisation was achieved only in patients who
completed the full decolonization treatment course for 5 days [28].
The decolonization treatment consisted of mupirocin nasal
ointment, chlorhexidine mouth rinse, and full-body wash with
chlorhexidine soap. In all these studies the success depends on how
many body regions are colonised by MRSA, as well as on the
compliance of the treatment protocol by the patients and the
health care workers.
This emphasizes the need for the development of additional
strategies for the decolonisation of bacteria. Cold atmospheric
plasma typically delivers up to 10
15 active molecules per cm
2 and
second. Here a plasma treatment time of approximately 6 min
delivered up to 3610
9 active molecules for 1 mm
2, which were
needed to destroy bacteria without any carrier medium. In
contrast active ingredients of anti-disinfectants have to be
immersed inside an appropriate carrier. When liquids are used
for disinfection, the active molecule delivery rate is roughly
10
24 cm
22 s
21.
Therefore it could be shown that the plasma treatment is very
efficient and fast in comparison with liquid treatment.
It is still under investigation why plasma treatment is so
effective. Recently, Kim et al. demonstrated a significant 3.83
log10 decrease of CFU of adherent S. aureus by employing a plasma
discharge in liquid using a reconstructed human skin model [14].
In this study liquid between the area of interest and the plasma
device was needed to generate reactive molecules to destroy the
bacteria. This means that the plasma device needs direct contact
to the area of interest. The advantage of the cold atmospheric
plasma treatment, which was used here, is that no direct contact
with the sample is necessary to kill the bacteria applied to the
stratum corneum. Our hypothesis is that the plasma produced gas
forms a ‘‘cocktail of reactive species’’ and due to synergetic
properties, the bactericidal effect is very pronounced. There are
three principal effects of plasma action: (I) permeabliisation of the
cell wall/membrane, leading to leakage of potassium; (II) access of
reactive species intracellular to induce oxidative/nitrosative burst;
(III) direct chemical reaction to DNA damage. All the reactions
depend on the non-equilibrium plasma chemistry (e.g. hydrogen
denaturation for membrane permeabilisation, density of ROS and
RNS species produced in air and then the reactions inside the cell
– e.g. Fenton’s reaction as an example, which involves H2O2). The
chemical composition produced by the plasma varies with power
and time and therefore might be designable so that no negative
impact on eukaryotic cells occurs [29]. In case of the mini-
FlatPlaSter a larger density of chemically reactive species is
produced with higher power input as compared to the FlatPlaSter
and because of that the inactivation speed is faster (fig. 5). As
described in the Results section both plasma devices used for this
study produce - amongst others species - ozone in the ppm region.
For sterilization of medical equipment or the in vivo treatment of
infected skin areas, it is planned to include a filter system using a
pump for toxic gas removal, to exchange the gas (air) between the
respective plasma treatments and to produce a ‘‘sufficiently
closed’’ volume which covers the area of interest. This means
that the transmission of possibly toxic components can be avoided.
Therefore the plasma is a good medium for energy transfer for
inactivating bacteria applied to vital skin.
Overall, the results demonstrate the considerable potential of
cold atmospheric plasma in decolonisation of pathogenic bacteria,
which were applied to intact skin surfaces in vitro. Using two
different plasma devices we were able to show, that a bacterial
reduction of up to 3 log10 steps was achieved for a 60 sec
(miniFlatPlaSter)/4 min (FlatPlaSter) plasma treatment; more
than a 5 log10 reduction was achieved after 8 min (FlatPlaSter)
of plasma treatment - without causing any damage to the porcine
skin. Although the applicability of this special approach using these
prototype devices is too long for hand disinfection at the moment,
cold atmospheric plasma might be a powerful tool for topical
contact-free use to prevent nosocomial transmission of multiresis-
tant pathogens, like MRSA, because here the full decolonisation
treatment course is much longer.
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